$MATV
Mativ Holdings, Inc. Stock $matv

$matv Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000100062323000031 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$668.3M	$679.0M	$406.8M
YoY Change	56.73%	66.91%	41.15%
Cost Of Revenue	$539.8M	$570.0M	$314.2M
YoY Change	65.18%	81.41%	51.49%
Gross Profit	$128.5M	$109.0M	$92.60M
YoY Change	29.02%	17.71%	14.6%
Gross Profit Margin	19.23%	16.05%	22.76%
Selling, General & Admin	$87.40M	$89.80M	$63.60M
YoY Change	55.52%	41.19%	52.15%
% of Gross Profit	68.02%	82.39%	68.68%
Research & Development	$7.000M	$9.100M	$5.200M
YoY Change	29.63%	75.0%	36.84%
% of Gross Profit	5.45%	8.35%	5.62%
Depreciation & Amortization	$42.80M	$42.00M	$25.10M
YoY Change	65.89%	67.33%	48.52%
% of Gross Profit	33.31%	38.53%	27.11%
Operating Expenses	$94.40M	$98.90M	$68.80M
YoY Change	53.25%	43.75%	50.88%
Operating Profit	$33.60M	$9.300M	$10.60M
YoY Change	-11.58%	-12.26%	-68.36%
Interest Expense	$28.20M	$26.50M	$14.50M
YoY Change	-242.42%	82.76%	400.0%
% of Operating Profit	83.93%	284.95%	136.79%
Other Income/Expense, Net	-$3.400M	$7.000M	$5.500M
YoY Change	-179.07%	27.27%	-311.54%
Pretax Income	$2.000M	-$10.20M	$1.600M
YoY Change	-86.39%	-737.5%	-94.29%
Income Tax	$6.600M	-$2.400M	$2.100M
% Of Pretax Income	330.0%		131.25%
Net Earnings	-$4.500M	-$7.700M	$1.600M
YoY Change	-138.14%	-581.25%	-92.59%
Net Earnings / Revenue	-0.67%	-1.13%	0.39%
Basic Earnings Per Share	-$0.08	-$0.14	$0.05
Diluted Earnings Per Share	-$0.08	-$0.14	$0.05
COMMON SHARES
Basic Shares Outstanding	54.84M shares	54.98M shares	31.16M shares
Diluted Shares Outstanding	54.66M shares	54.48M shares	31.41M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$107.6M	$97.00M	$56.10M
YoY Change	91.12%	72.91%	-11.93%
Cash & Equivalents	$107.6M	$97.00M	$56.10M
Short-Term Investments
Other Short-Term Assets	$36.20M	$38.80M	$20.60M
YoY Change	58.77%	88.35%	38.26%
Inventory	$521.6M	$544.4M	$272.4M
Prepaid Expenses
Receivables	$277.5M	$304.2M	$278.5M
Other Receivables	$20.30M	$20.80M	$3.700M
Total Short-Term Assets	$963.2M	$1.005B	$638.0M
YoY Change	47.35%	57.55%	49.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$874.7M	$872.4M	$450.4M
YoY Change	105.23%	93.69%	38.97%
Goodwill	$874.9M	$871.0M	$646.8M
YoY Change		34.66%	60.98%
Intangibles	$660.2M	$674.9M	$496.7M
YoY Change		35.88%	62.96%
Long-Term Investments	$56.10M	$59.80M	$66.80M
YoY Change	-11.51%	-10.48%	11.33%
Other Assets	$121.8M	$105.6M	$106.6M
YoY Change	-13.68%	-0.94%	55.62%
Total Long-Term Assets	$2.686B	$2.670B	$1.804B
YoY Change	54.21%	47.99%	55.59%
TOTAL ASSETS
Total Short-Term Assets	$963.2M	$1.005B	$638.0M
Total Long-Term Assets	$2.686B	$2.670B	$1.804B
Total Assets	$3.649B	$3.675B	$2.442B
YoY Change	52.34%	50.49%	53.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$214.4M	$253.5M	$122.8M
YoY Change	73.88%	106.43%	84.38%
Accrued Expenses	$151.1M	$154.5M	$116.3M
YoY Change	33.84%	32.85%	39.28%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$34.70M	$35.10M	$2.900M
YoY Change	1726.32%	1110.34%	7.41%
Total Short-Term Liabilities	$426.2M	$468.5M	$243.4M
YoY Change	75.54%	92.48%	54.34%
LONG-TERM LIABILITIES
Long-Term Debt	$1.713B	$1.698B	$1.274B
YoY Change	36.74%	33.33%	107.01%
Other Long-Term Liabilities	$57.60M	$51.30M	$76.80M
YoY Change	-52.04%	-33.2%	20.57%
Total Long-Term Liabilities	$1.771B	$1.749B	$76.80M
YoY Change	28.97%	2177.6%	-88.69%
TOTAL LIABILITIES
Total Short-Term Liabilities	$426.2M	$468.5M	$243.4M
Total Long-Term Liabilities	$1.771B	$1.749B	$76.80M
Total Liabilities	$2.500B	$2.516B	$1.741B
YoY Change	46.98%	44.53%	86.23%
SHAREHOLDERS EQUITY
Retained Earnings	$551.2M	$579.3M	$681.2M
YoY Change		-14.96%	1.54%
Common Stock	$5.500M	$5.500M	$3.100M
YoY Change		77.42%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.149B	$1.159B	$701.4M
YoY Change
Total Liabilities & Shareholders Equity	$3.649B	$3.675B	$2.442B
YoY Change	52.34%	50.49%	53.82%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$4.500M	-$7.700M	$1.600M
YoY Change	-138.14%	-581.25%	-92.59%
Depreciation, Depletion And Amortization	$42.80M	$42.00M	$25.10M
YoY Change	65.89%	67.33%	48.52%
Cash From Operating Activities	$40.20M	-$20.70M	$5.000M
YoY Change	209.23%	-514.0%	-60.63%
INVESTING ACTIVITIES
Capital Expenditures	$23.30M	$19.10M	$8.700M
YoY Change	-337.76%	119.54%	22.54%
Acquisitions
YoY Change
Other Investing Activities	$3.200M	$200.0K	$0.00
YoY Change	-91.44%		-100.0%
Cash From Investing Activities	-$20.10M	-$19.40M	-$9.600M
YoY Change	-172.83%	102.08%	31.51%
FINANCING ACTIVITIES
Cash Dividend Paid		$22.00M	$13.90M
YoY Change		58.27%	0.72%
Common Stock Issuance & Retirement, Net			$2.900M
YoY Change			-6.45%
Debt Paid & Issued, Net		$19.50M	$14.40M
YoY Change		35.42%	2300.0%
Cash From Financing Activities	-9.700M	$11.70M	-$13.60M
YoY Change	-74.41%	-186.03%	-402.22%
NET CHANGE
Cash From Operating Activities	40.20M	-$20.70M	$5.000M
Cash From Investing Activities	-20.10M	-$19.40M	-$9.600M
Cash From Financing Activities	-9.700M	$11.70M	-$13.60M
Net Change In Cash	10.40M	-$27.40M	-$18.60M
YoY Change	285.19%	47.31%	-306.67%
FREE CASH FLOW
Cash From Operating Activities	$40.20M	-$20.70M	$5.000M
Capital Expenditures	$23.30M	$19.10M	$8.700M
Free Cash Flow	$16.90M	-$39.80M	-$3.700M
YoY Change	-25.88%	975.68%	-166.07%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30022
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001000623
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	1-13948
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	MATIV HOLDINGS, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	62-1612879
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	100 North Point Center East,
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 600
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Alpharetta,
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2023Q1	dei	City Area Code CityAreaCode	800
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	514-0186
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, $0.10 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	MATV
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	54842300	shares
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	679000000.0	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	406800000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	570000000.0	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	314200000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	109000000.0	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	92600000	usd
CY2023Q1	us-gaap	Selling Expense SellingExpense	23900000	usd
CY2022Q1	us-gaap	Selling Expense SellingExpense	14300000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9100000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5200000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	65900000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	49300000	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	98900000	usd
CY2022Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	68800000	usd
CY2023Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	800000	usd
CY2022Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	13200000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	9300000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	10600000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	26500000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	14500000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7000000.0	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5500000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10200000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1600000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2400000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2100000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	100000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2100000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-7700000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1600000	usd
CY2023Q1	us-gaap	Dividends Dividends	100000	usd
CY2022Q1	us-gaap	Dividends Dividends	200000	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-7800000	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Diluted UndistributedEarningsLossAvailableToCommonShareholdersDiluted	-7800000	usd
CY2022Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Diluted UndistributedEarningsLossAvailableToCommonShareholdersDiluted	1400000	usd
CY2022Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	1400000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54483000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31158000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54483000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31413700	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-7700000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1600000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	18400000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	8700000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-17200000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	21600000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-5800000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-1100000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	500000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	-700000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7500000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	30700000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-200000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	32300000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97000000.0	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	124400000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	304200000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	266800000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	544400000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	534900000	usd
CY2023Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	20800000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	19700000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	38800000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	28900000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1005200000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	974700000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	872400000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	874900000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	17200000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	17400000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33700000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	35800000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	35000000.0	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	34400000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	59800000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	59100000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	871000000.0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	847200000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	674900000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	710300000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	105600000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	115400000	usd
CY2023Q1	us-gaap	Assets Assets	3674800000	usd
CY2022Q4	us-gaap	Assets Assets	3669200000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	35100000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	34600000	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	900000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	900000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8900000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9300000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	253500000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	225700000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	15600000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	11400000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	154500000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	184200000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	468500000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	466100000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1697900000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1659300000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	17800000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	17600000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27300000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	29700000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	14600000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	14600000	usd
CY2023Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	79800000	usd
CY2022Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	81600000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	158300000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	172200000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	51300000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	48800000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	2515500000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2489900000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54919923	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54919923	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54929973	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54929973	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	5500000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5500000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	662400000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	658500000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	579300000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	610700000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-87900000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-95400000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1159300000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1179300000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3674800000	usd
CY2023Q1	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	100	country
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3669200000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	682200000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1600000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	30700000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.44
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	13900000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3400000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	300000	usd
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	2900000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	701400000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1179300000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-7700000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7500000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.40
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	22400000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	100000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3700000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	100000	usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1300000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1159300000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-7700000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1600000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	42000000.0	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23900000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1800000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1200000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	12900000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7100000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6400000	usd
CY2023Q1	matv	Pension And Other Postretirement Benefit Expense Net Of Pension And Other Postretirement Benefit Contributions PensionAndOtherPostretirementBenefitExpenseNetOfPensionAndOtherPostretirementBenefitContributions	-3700000	usd
CY2022Q1	matv	Pension And Other Postretirement Benefit Expense Net Of Pension And Other Postretirement Benefit Contributions PensionAndOtherPostretirementBenefitExpenseNetOfPensionAndOtherPostretirementBenefitContributions	-1900000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3700000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3400000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	100000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2100000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2400000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3600000	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	usd
CY2022Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-2200000	usd
CY2023Q1	matv	Payments For Proceeds From Derivative Instrument Operating Activities PaymentsForProceedsFromDerivativeInstrumentOperatingActivities	0	usd
CY2022Q1	matv	Payments For Proceeds From Derivative Instrument Operating Activities PaymentsForProceedsFromDerivativeInstrumentOperatingActivities	-23600000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	37700000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	42800000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8100000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16800000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	10000000.0	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	6800000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3300000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	16100000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	500000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	4900000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	52000000.0	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	45400000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20700000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5000000.0	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19100000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8700000	usd
CY2023Q1	us-gaap	Payments For Software PaymentsForSoftware	100000	usd
CY2022Q1	us-gaap	Payments For Software PaymentsForSoftware	900000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	200000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19400000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9600000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	22000000.0	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	13900000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	55000000.0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	20000000.0	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	19500000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	14400000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2200000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	200000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	200000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1300000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2900000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-300000	usd
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11700000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13600000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1000000.0	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-400000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-27400000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18600000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	124400000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	74700000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97000000.0	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	56100000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	25600000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	7600000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2300000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3400000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	7600000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5300000	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	General<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nature of Business</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 6, 2022, Schweitzer-Mauduit International, Inc. ("SWM") consummated its previously announced merger transaction involving Neenah, Inc. ("Neenah"). A wholly-owned subsidiary of SWM merged with and into Neenah (the "Merger"), with Neenah surviving the Merger as a direct and wholly-owned subsidiary of SWM. Effective as of the closing date of the Merger, SWM changed its name to Mativ Holdings, Inc. ("Mativ," "we," "our," or the "Company"). Mativ is a global leader in specialty materials headquartered in Alpharetta, Georgia, United States of America. The Company offers a wide range of critical components and engineered solutions to solve customers' most complex challenges, targeting premium applications across diversified and growing end markets. Combined with global manufacturing, supply chain, innovation, and material science capabilities, our broad portfolio of technologies combines polymers, fibers, and resins to optimize the performance of customers' products across multiple stages of the value chain. Effective with the Merger, the Company changed the name of its two reporting segments to: Advanced Technical Materials ("ATM") and Fiber-Based Solutions ("FBS"). There was no change to the historical reporting segments or historical results for the segments. Refer to Note 15. Segment Information for additional information on our segments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business in approximately 100 countries and operate 47 production locations worldwide, with offices and facilities in the United States, United Kingdom, China, Germany, France, Belgium, Poland, India, Brazil, Canada, Spain, Italy, Mexico, Netherlands, Malaysia, and Luxembourg. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements and the notes thereto have been prepared in accordance with the instructions on Form 10-Q and Rule 10-01 of Regulation S-X of the Securities and Exchange Commission ("SEC") and do not include all the information and disclosures required by accounting principles generally accepted in the United States of America ("GAAP"). However, such information reflects all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of results for the interim periods.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the full year. The unaudited condensed consolidated financial statements and these notes thereto included herein should be read in conjunction with the audited consolidated financial statements and the related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on March 1, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts on the unaudited Condensed Consolidated Statements of Cash Flows have been reclassified to conform to the current year presentation for comparative purposes. Prior year's classification of certain end markets in the legacy SWM Advanced Materials & Structures segment have been reclassified to conform to the current year presentation of ATM's end markets for comparative purposes. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned, majority-owned and controlled subsidiaries. The Company’s share of the net income of its 50%-owned joint ventures in China is included in the unaudited Condensed Consolidated Statements of Income (Loss) as Income from equity affiliates, net of income taxes. Intercompany balances and transactions have been eliminated. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the revenues and expenses during the reporting period. Actual results could differ significantly from these estimates. The significant estimates underlying our unaudited condensed consolidated financial statements include, but are not limited to, inventory valuation, useful lives of tangible and intangible assets, business acquisitions, equity-based compensation, derivatives, receivables valuation, pension, postretirement and other benefits, taxes and contingencies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." The new standard provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform and the anticipated discontinuance of the London Interbank Offered Rate ("LIBOR") if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. In December 2022, FASB issued ASU 2022-06, "Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848", which extended the final sunset date from December 31, 2022 to December 31, 2024. The provisions of ASU 2020-04 and ASU 2022-06 were adopted effective April 1, 2022 and December 21, 2022, respectively, and did not have a material impact on the unaudited condensed consolidated financial statements.</span></div>
CY2022Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q1	matv	Number Of Production Locations NumberOfProductionLocations	47	production_location
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	ReclassificationsCertain prior year amounts on the unaudited Condensed Consolidated Statements of Cash Flows have been reclassified to conform to the current year presentation for comparative purposes. Prior year's classification of certain end markets in the legacy SWM Advanced Materials & Structures segment have been reclassified to conform to the current year presentation of ATM's end markets for comparative purposes.
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the revenues and expenses during the reporting period. Actual results could differ significantly from these estimates. The significant estimates underlying our unaudited condensed consolidated financial statements include, but are not limited to, inventory valuation, useful lives of tangible and intangible assets, business acquisitions, equity-based compensation, derivatives, receivables valuation, pension, postretirement and other benefits, taxes and contingencies.</span></div>
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	679000000.0	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	406800000	usd
CY2022Q4	matv	Accounts Receivable Sale Agreement Maximum Commitment AccountsReceivableSaleAgreementMaximumCommitment	175000000	usd
CY2022Q4	matv	Accounts Receivable Sales Agreement Term AccountsReceivableSalesAgreementTerm	P3Y
CY2023Q1	us-gaap	Accounts Receivable Sale AccountsReceivableSale	312100000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	308800000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	6900000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-600000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7500000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	29800000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-900000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	30700000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7800000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1400000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-7700000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	1600000	usd
CY2023Q1	us-gaap	Dividends Dividends	100000	usd
CY2022Q1	us-gaap	Dividends Dividends	200000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-7800000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1400000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54483000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31158000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	255700	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54483000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31413700	shares
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	203500000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	206000000.0	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	88100000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	80500000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	231800000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	223900000	usd
CY2023Q1	us-gaap	Inventory Supplies Net Of Reserves InventorySuppliesNetOfReserves	21000000.0	usd
CY2022Q4	us-gaap	Inventory Supplies Net Of Reserves InventorySuppliesNetOfReserves	24500000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	544400000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	534900000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	847200000	usd
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	16500000	usd
CY2023Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	7300000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	871000000.0	usd
CY2023Q1	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-25300000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14500000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11100000	usd
CY2023Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	800000	usd
CY2022Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	13200000	usd
CY2023Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	800000	usd
CY2022Q1	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	13200000	usd
CY2023Q1	us-gaap	Restructuring Costs RestructuringCosts	1300000	usd
CY2022Q1	us-gaap	Restructuring Costs RestructuringCosts	13200000	usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	4900000	usd
CY2021Q4	us-gaap	Restructuring Reserve RestructuringReserve	6200000	usd
CY2023Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	500000	usd
CY2022Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	1400000	usd
CY2023Q1	us-gaap	Restructuring Reserve Translation And Other Adjustment RestructuringReserveTranslationAndOtherAdjustment	-100000	usd
CY2022Q1	us-gaap	Restructuring Reserve Translation And Other Adjustment RestructuringReserveTranslationAndOtherAdjustment	100000	usd
CY2023Q1	us-gaap	Restructuring Reserve RestructuringReserve	4500000	usd
CY2022Q1	us-gaap	Restructuring Reserve RestructuringReserve	4700000	usd
CY2023Q1	us-gaap	Other Long Term Debt OtherLongTermDebt	600000	usd
CY2022Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	900000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	27700000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	29400000	usd
CY2023Q1	matv	Long Term Debt And Other Gross LongTermDebtAndOtherGross	1733000000	usd
CY2022Q4	matv	Long Term Debt And Other Gross LongTermDebtAndOtherGross	1693900000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	35100000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	34600000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1697900000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1659300000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	31400000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	41300000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	41400000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	382400000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	937000000.0	usd
CY2023Q1	matv	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	327300000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	1760800000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	30200000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	15600000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	44900000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	13700000	usd
CY2023Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	4000000	usd
CY2022Q1	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2500000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.235
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	1.313
CY2022Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	679000000.0	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	406800000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	9300000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	10600000	usd

Files In Submission

Name	View Source	Status
0001000623-23-000031-index-headers.html	Edgar Link	pending
0001000623-23-000031-index.html	Edgar Link	pending
0001000623-23-000031.txt	Edgar Link	pending
0001000623-23-000031-xbrl.zip	Edgar Link	pending
ex101-separationagreement.htm	Edgar Link	pending
ex102-psuawardagreementfin.htm	Edgar Link	pending
ex103-rsuawardagreementfin.htm	Edgar Link	pending
ex104-defcompplan2.htm	Edgar Link	pending
ex105-defcompplan2fornonxe.htm	Edgar Link	pending
ex211-subsidiaries3312023.htm	Edgar Link	pending
ex31103312023.htm	Edgar Link	pending
ex31203312023.htm	Edgar Link	pending
ex3203312023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
matv-20230331.htm	Edgar Link	pending
matv-20230331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
matv-20230331_def.xml	Edgar Link	unprocessable
matv-20230331_cal.xml	Edgar Link	unprocessable
matv-20230331_lab.xml	Edgar Link	unprocessable
matv-20230331_pre.xml	Edgar Link	unprocessable
matv-20230331_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MATV
Mativ Holdings, Inc. Stock $matv

2023 Q2 Form 10-Q Financial Statement

#000100062323000031 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MATV Mativ Holdings, Inc. Stock $matv

2023 Q2 Form 10-Q Financial Statement

#000100062323000031 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MATV
Mativ Holdings, Inc. Stock $matv